's syndrome (AS) Is mannested by progressive renal dlsease wnh typlcal basement membranes morpholcgy and frequent agsoclanon wnh ocular slgns and deafness. Thls hereditary dlsease has been asslgned to the collagen type N alpha 5 gene (COL4A5) located on X chromosome and several rnutatlons have been reported.
Uslng standard Southern blot technique and cDNA probes of COL4A5 absence of restrlctlon fragments or presence of 'junction' fragments proved a mechanism of the mutation. The soan of delellon varled at least from 1.6 lo 84 kb. Nonetheless the bask cllnlcal features of the famllles were Indifferent. Deletlon of promoter reglon of COL4A5 I n famlty TR, whlch mlght atfected another gene, was assoclated wlth generalized lelomyomatosls In AS patlents -a rare syndromal phenomenon. 19% Reusz and his colleagues reported that hyperoxaluria during phosphate supplementation in XLH might contribute to the development of nephrocalcinosis in this discorder. We analysed 18 random urine samples from 11 children wit11 XLH (age:3.0-11.0 years) who were treated with 1-4g elemental phosphorusfday, given in four to six single doses, and 30-60 ng 1.25(0H)ZD3(kgiday given in two divided doses. There were no signs of severe nephrocalcinosis or renal stones. Urines were collected at about 9 AM alter an overnight fast and after the bladder was emptied at about 6 AM. Oxalale excretion was andyscd by a enzymatic method and the results were compared with oxalate excretion in random urincs from 19 healthy children (age: 4.0-17.0 years).
Famlty
The oxalate excretion was significanlly bigher (c 0.01) in XLH (lS,9-l87,2 pumg creatinine) compared to our control group (1,3-27 pg/mg crea). There was a positive relationship between the oxalate and phosphate excretion, both values being relative to crealuiinc excretion (r =0.71p < 0.01).
In conclusion, we found an elevated oxdalc excretion in patients with XLH with appears to be dependent on the phosphate excretion, which in turn is known to be dependent on phosphate intake in XLH. Further long-term studies are necessary to determine whcther liyperoxaluria is of clinical relevance for development of nephrocdcinosis in XLH. in patients with propionic acidaemia (PA) and methylmalonic acidaemia (MMA) the increased concentration of propionyl-CoA in cells leads to a relative abundance of odd-numbered long-chain fatty acids (OLCFA) in body lipids. During a period of 5 years we used the OLCFA content i n erythrocyte membranes for long-term metabolic control in 5 patients with PA. The determination of OLCFA in erythrocyte membrane lipids was done by capillary column gas liquid chromatography and the sums of the individual OLCFA-C15:0, C17:O and C17:l-were calculated and expressed as a percentage of the total C14-C22 fatty acids.
ODD-NUMBERED LONG-CHAIN
In 3 patients OLCFA are usually below 1.9% indicating a good metabalic control.
In one patient, metabolic control is fair (OLCFA < 3.1%) and one neonate with severe course of P A showed a decrease of OLCFA with age and an increase during metabolic decompensation before death. In general, during acute metabolic crisis we only found an elevation of propionic acid in plasma. After crisis there was a delayed increase of OLCFA. I n one patient a decrease of OLCFA could be seen after therapy w~th metronidazole. OLCFA seem to be a valuable parameter for long-term metabolic control in patients with PA.
MOLECULAR ANALYSI
F PKU I N POLAND Marta pgulska'lP, Antonin 17ige12, A g n i e s i 5 a utkowska , J a c e k J. p i e t r z y k l and JUrgen H o r s t .
'Department of Medical G e n e t i c s , I n s t i t u t of P e d i a t r i c s , Krakow, Poland. I n s t i t u t f u r Humanqenetik d e r U n i v e r s i t x t , Vesaliusweg 12-14, W-4400 Munster, Germany.
To i n v e s t i g a t e t h e m o l e c u l a r b a s i s i n p h e n y l k e t o n u r i a (PKU) i n t h e p o p u l a t i o n of s o u t h e r n Poland we c h a r a c t e r i z e d t h e r e s t r i c t i o n l e n g h t polymorphism (RFLP) h a p l o t y p e s a t t h e p h e n y l a l a n i n e h y d r o x y l a s e g e n e l o c u s , s c r e e n e d f o r m u t a t i o n s w i t h a l l e l e -s p e c i f i c o l i g o n u c l e o t i d e s by a m p l i f i c a t i o n of t h e genomic DNA w i t h t h e polymerase c h a i n r e a c t i o n and sequenced t h e exons of t h e PAH gene from 23 PKU f a m i l i e s .
71.7% of a l l PKU a l l e l e s a r e c h a r a c t e r i z e d by t h e f o l l o w i n g f i v e m u t a t i o n s : codon R408W, R261Q. R158Q, R252W and t h e s p l i c i n g d e f e c t i n i n t r o n 10. The s p l i c e m u t a t i o n i n i n t r o n 10 was d e t e c t e d by DdeI r e s t r i c t i o n a n a l y s i s . I n t h e i n v e s t i g a t e d f a m i l i e s t h e o v e r a l l f r e q u e n c y f o r George's Hospital Medical School Lordon U.K.
I n previous experimental studies we have found 47 % incidence of congenital cataracts among the fetuses of manifestly diabetic (MD) rats, and 4 % in the offspring of normal (N) rats. The aim of the study was to clarify the role of the sorbitol shunt in the pathogenesis of this congenital defect. Light microscopical evaluation of the lenses of day 16-22 fetuses revealed excessive formation of vacuoles in offspring of MD rats compared to N offspring a t all time points. On gestational day 16 we found a doubled aldose reductase (AR) activity in the fetuses of MD rats compared to the N fetuses. This difference a s well a s the net activity of AR decreased in both groups during subsequent development. The sorbitol concentration was increased more t h a n tenfold i n the MD fetal lenses compared to N fetal lenses a t all time points. The sorbitol concentration in both the MD and the N group decreased from day 16 to day 20 and increased again elightly on day 22.
We conclude that the diabetic uterine milieu induces AR activity and sorbitol formation i n the lens. This over-activity of the sorbitol shunt may produce metabolic and osmotic imbalance in the fetal lens, resulting in excessive vacuole formation and subsequent development of congenital cataract. . WAC can be used to m n i t o r bone developmmt i n neonates.
